,i  #aad? ,,congress  #a/ ,session  ,h4 
,r4 #bdcc  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,may #ai1 #bjae ,mr4  
,bilirakis introduc$ ! foll[+ bill2 :i* 
0 ref]r$ to ! ,committee on ,en]gy &    
,comm]ce  ,a ,,bill  ,to am5d ! ,f$]al  
,food1 ,drug1 & ,cosmetic ,act ) respect
 to enhanc+ comb9ation products review4 
#a4 ,enhanc+ comb9ation products review 
,section #ejc7;g77#d77;,c7 ( ! ,f$]al   
,food1 ,drug1 & ,cosmetic ,act 7#ba     
,u4,s4,c4 #cec7;g77#d77;,c77 is am5d$ by
 add+ at ! end ! foll[+ new clause3     
7iii7 ,n lat] ?an #ah mon?s aft] ! date 
( ! enactm5t ( ! #ba/ ,c5tury ,cures    
,act1 ! ,secret>y %all issue f9al       
guidance t describes ! responsibilities 
( ea* ag5cy c5t] reg>d+ its review (    
comb9ation products4 ,! ,secret>y %all1 
aft] solicit+ public comm5t1 review &   
update ! guidance p]iodically4  4